OptimizeRx Expands Ad Platform to OTC Health Brands
Marketers can now leverage EHR-based programmatic ad inventory to target specific patient populations more efficiently.
Updated on Oct. 26, 2026 in Advertising
Live Poll
Do you trust seeing pharmaceutical advertisements while your doctor manages your electronic health records?
In October 2026, healthcare software firm OptimizeRx finalized a programmatic advertising partnership with The Trade Desk. This move enables the company to integrate data from electronic health record (EHR) platforms with broader digital media channels to expand its client base.
Why it matters
OptimizeRx is diversifying its revenue beyond prescription drug brands, which currently account for over 99% of its advertising income. By leveraging The Trade Desk, the firm aims to capture new market segments such as over-the-counter healthcare product marketers.
Currently, over 99% of the company's advertising revenue stems from prescription drug brands. OptimizeRx is now pivoting to reach other healthcare product marketers, a shift that remains unquantified in terms of expected revenue impact.
The players
OptimizeRx
A provider of digital health software that integrates advertising directly into physician electronic health record interfaces.
The Trade Desk
A technology platform that enables agencies and brands to manage programmatic advertising campaigns across various digital channels.
DeepIntent
A healthcare-focused programmatic advertising platform that serves as a previous partner for OptimizeRx.
The details
OptimizeRx provides software that integrates directly into physician prescription and record-keeping systems. By using National Provider Identifier (NPI) numbers for precision targeting, the company displays programmatic ads within EHR portals during clinical workflows. The partnership with The Trade Desk allows these specialized ads to be compared and managed alongside broader media buys, facilitating campaigns for products like over-the-counter allergy brands.
Timeline
Earlier this year, OptimizeRx initiated a programmatic advertising partnership with DeepIntent.
The programmatic advertising partnership with The Trade Desk was formed in October 2026.
Market Landscape
This partnership follows the earlier agreement with DeepIntent, signaling a strategic shift toward multi-platform programmatic advertising. The move allows OptimizeRx to move beyond its established niche of prescription drug marketing toward broader healthcare consumer products.
Healthcare marketers and vendors should note the expanded capability to run programmatic ads against EHR-integrated NPI-targeted campaigns. Operators in the over-the-counter space should track whether these new ad inventory channels deliver measurable changes in patient purchase behavior.
The takeaway
The firm is moving to decouple its revenue from a near-total reliance on prescription drug brands. Operators should monitor how EHR-based programmatic placements perform for consumer-facing goods compared to traditional digital display channels.
Further reading
For broader trends in digital marketing and health-tech, explore the latest developments in Advertising.
Source note: This article includes information reported by AdExchanger.
Live Poll
Do you trust seeing pharmaceutical advertisements while your doctor manages your electronic health records?
